Is Cassava Sciences Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Cassava Sciences Inc (SAVA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cassava Sciences Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cassava Sciences Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Cassava Sciences Inc?

Muslim investors may consider investing in Cassava Sciences Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cassava Sciences Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Cassava Sciences Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cassava Sciences Inc updated?

The Shariah compliance status of Cassava Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cassava Sciences Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cassava Sciences Inc?

You can check the latest Shariah compliance status of Cassava Sciences Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SAVA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 14, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Cassava Sciences Inc (SAVA)

Based on 7 analysts giving stock ratings to Cassava Sciences Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Cassava Sciences Inc. Stock Analysis SAVA

United States Health Care Micro Cap Report: 2025 Annual

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. The company is headquartered in Austin, Texas and currently employs 30 full-time employees. The company went IPO on 2000-07-14. The firm's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. The company has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Key Statistics of Cassava Sciences Inc (SAVA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.19$2.49

Today's Open

$2.19

Volume

251.10K

P/E Ratio (TTM)

52 Week Range

$1.15$4.98

Market Cap

98.55M

Avg. Volume

452.87K

Dividend Yield

Financial Metrics & Statements of Cassava Sciences Inc (SAVA)

FAQ's for Cassava Sciences Inc (SAVA)

According to Musaffa’s Shariah screening methodology, Cassava Sciences Inc (SAVA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.